Healthy Blood Sugar Support
Developed in collaboration with Jennifer McManus, RD, LDN, CDCES
Disclaimer
The Pendulum team has created this protocol in collaboration with practitioners to assist healthcare partners during the creation of individualized patient treatment plans. When using this protocol, you should understand and accept that the recommendations in the protocol are for educational guidance and need to be adapted to meet individual patient needs. This may not be appropriate for every patient.
This protocol is not a substitute for medical advice or intended to diagnose or treat any medical condition.
Description
A growing body of evidence suggests that specific, naturally occurring gut bacteria, particularly Akkermansia muciniphila and butyrate-producing microbes, are under-represented in the intestinal tracts. The functions of these microbes, specifically maintenance of gut barrier integrity and butyrate production, are important to already healthy glucose and insulin levels. (1)
The short-chain fatty acid, butyrate, is shown to be essential in glucose management by binding to receptors in the gut mucosa and stimulating the release of glucagon-like peptide-1 (GLP-1). (1)
In addition to supporting healthy glucose levels, GLP-1 promotes satiety and supports cardiovascular and general metabolic health. In a placebo-controlled clinical trial, subjects administered a proprietary blend of Clostridium butyricum, Anaerobutyricum hallii, Clostridium beijerinckii, Akkermansia muciniphila, and Bifidobacterium infantis supported healthy glucose levels. (1)
This five-strain formulation is available as Glucose Control.
Pendulum supplement plan
- Glucose Control: 1 capsule, twice daily with food
- Polyphenol Booster: optional add-on to boost Akkermansia, which may further enhance the benefits
Disclaimer
The Fullscript Integrative Medical Advisory team has developed or collected these protocols from practitioners and supplier partners to help health care practitioners make decisions when building treatment plans. By adding this protocol to your Fullscript template library, you understand and accept that the recommendations in the protocol are for initial guidance and may not be appropriate for every patient.
- Perraudeau F, McMurdie P, Bullard J, et al. BMJ Open Diabetes Research and Care 2020;8:e001319. doi: 10.1136/bmjdrc-2020-001319
Fullscript content philosophy
At Fullscript, we are committed to curating accurate, and reliable educational content for practitioners and patients alike. Our educational offerings cover a broad range of topics related to integrative medicine, such as supplement ingredients, diet, lifestyle, and health conditions.
Medically reviewed by expert practitioners and our internal Integrative Medical Advisory team, all Fullscript content adheres to the following guidelines:
- In order to provide unbiased and transparent education, information is based on a research review and obtained from trustworthy sources, such as peer-reviewed articles and government websites. All medical statements are linked to the original reference and all sources of information are disclosed within the article.
- Information about supplements is always based on ingredients. No specific products are mentioned or promoted within educational content.
- A strict policy against plagiarism is maintained; all our content is unique, curated by our team of writers and editors at Fullscript. Attribution to individual writers and editors is clearly stated in each article.
- Resources for patients are intended to be educational and do not replace the relationship between health practitioners and patients. In all content, we clearly recommend that readers refer back to their healthcare practitioners for all health-related questions.
- All content is updated on a regular basis to account for new research and industry trends, and the last update date is listed at the top of every article.
- Potential conflicts of interest are clearly disclosed.